Titan-iR Advance Biotherapeutic therapy is an innovative treatment approach that utilizes an unique form of transcranial photobiomodulation in the the form of advanced biotherapeutics to optimize brain functionality and promote mental wellness.

This therapy works by targeting and optimizing the biochemical functions in the brain which increases adenosine triphosphate (ATP) levels. This helps maintain a delicate balance of biochemicals necessary for optimal brain activity.

Titan-iR Advanced Biotherapeutic therapy can be beneficial for various conditions related to brain health and mood wellness, including focus disorders, mood stabilization, and productivity disorders.

As with any neuromodulation therapy, there may be potential side effects. The most common side-effects are light headache, inattention, and overstimulation. However, these specific side effects of Titan-iR Advance Biotherapeutic therapy are minimal and generally well-tolerated by patients. It's important to consult with a healthcare professional for personalized information.

The timeline for results can vary depending on the individual and the specific condition being treated. Some patients may start experiencing improvements within a few weeks, while others may require longer-term therapy for optimal outcomes. Medify recommends a minimum of 15 therapeutic sessions to achieve best results.

Titan-iR Advance Biotherapeutic therapy is designed to cater to individual needs and conditions. However, it is important to consult with a healthcare professional to determine if this therapy is suitable for your specific situation and medical history.

Typical transcranial medical device treatments modulate the electric potential of a neuron. These are electric or magnetic current devices such as Electric Convulsive Therapy (ECT), Transcranial Direct or Alternating Current Stimulation (tDCS), or Repetitive Transcranial Magnetic Stimulation (rTMS or TMS).

Many published studies include patients receiving photobiomodulation in combination with psychotherapy and antidepressant medications. No serious adverse events were reported for these combinations. There are no reports on combining photobiomodulation with other transcranial treatments such as rTMS, TDCS, or ECT. Researchers have deduced that there is no rationale for avoiding the simultaneous use of photobiomodulation with other device-based therapies. Secondary effects of potentiation of the antidepressant effects might occur, and some side effects, such as memory impairment with ECT, can potentially be mitigated.